← Back to Clinical Trials
Recruiting NCT06324864

NCT06324864 START NOW Adapted: Culturally Adapted Version of START NOW

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06324864
Status Recruiting
Phase
Sponsor Prof. Christina Stadler
Condition Depression
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-03-13
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
START NOW Adapted

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2024-03-13 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test the effectiveness of the culturally adapted skills-training START NOW in youth migrant populations. The main question it aims to answer is: Is the culturally adapted skills training START NOW more effective than treatment as usual (TAU) in reducing mental health problems in migrants? Participants will be randomly assigned to the intervention group receiving the skills training START NOW Adapted or the control group receiving TAU. Researchers will compare both groups to see if START NOW Adapted is more effective than TAU in reducing mental health problems in migrants.

Eligibility Criteria

Inclusion Criteria: * Being a migrant resettled in Switzerland temporarily or permanently * Aged between 14 and 18 * Able to speak, read and understand one of the following languages: German, English, Turkish, Farsi, Dari, Ukrainian, Algerian Arabic or Pashto * Able to give informed consent as documented by signature * At least sub-clinical depressive symptoms assessed by the Hopkins Symptom Checklist-25 (HSCL-25); total score \> 1.75, OR * Having elevated levels of psychological distress assessed by Kessler Psychological Distress Scale (K10); total score \> 20 Exclusion Criteria: * Suicidality assessed in self-report by the Suicide Behaviors Questionnaire-Revised (SBQ-R; total score \> 6) and external report by telephone clarification * Planning to leave Switzerland in the next 6 months * Concurrent CBT-based skills-training similar to START NOW

Contact & Investigator

Central Contact

Janine Bacher, MSc

✉ janine.bacher@upk.ch

📞 +41 61 325 8048

Principal Investigator

Janine Bacher, MSc

PRINCIPAL INVESTIGATOR

University Psychiatric Clinics Basel

Frequently Asked Questions

Who can join the NCT06324864 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 18 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06324864 currently recruiting?

Yes, NCT06324864 is actively recruiting participants. Contact the research team at janine.bacher@upk.ch for enrollment information.

Where is the NCT06324864 trial being conducted?

This trial is being conducted at Basel, Switzerland.

Who is sponsoring the NCT06324864 clinical trial?

NCT06324864 is sponsored by Prof. Christina Stadler. The principal investigator is Janine Bacher, MSc at University Psychiatric Clinics Basel. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology